Quantifying GABA in Addiction: A Review of Proton Magnetic Resonance Spectroscopy Studies.

1H-MRS GABA MRS addiction magnetic resonance spectroscopy metabolites neurochemistry neuroimaging substance use disorder γ-aminobutyric acid

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
13 07 2022
Historique:
received: 31 05 2022
revised: 07 07 2022
accepted: 09 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Gamma-aminobutyric acid (GABA) signaling plays a crucial role in drug reward and the development of addiction. Historically, GABA neurochemistry in humans has been difficult to study due to methodological limitations. In recent years, proton magnetic resonance spectroscopy (

Identifiants

pubmed: 35884725
pii: brainsci12070918
doi: 10.3390/brainsci12070918
pmc: PMC9316447
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Ann N Y Acad Sci. 2010 Feb;1187:148-71
pubmed: 20201852
Addict Biol. 2020 Jan;25(1):e12702
pubmed: 30561840
Psychiatry Res. 2014 Dec 30;224(3):281-7
pubmed: 25444536
NMR Biomed. 2009 Aug;22(7):762-9
pubmed: 19388001
Drug Alcohol Depend. 2013 May 1;129(3):232-9
pubmed: 23522493
Am J Psychiatry. 1999 Jun;156(6):952-4
pubmed: 10360140
Magn Reson Imaging. 1995;13(6):853-69
pubmed: 8544657
Exp Biol Med (Maywood). 2021 May;246(9):1069-1083
pubmed: 33554649
Magn Reson Imaging. 2011 Jan;29(1):19-24
pubmed: 20884148
Biol Psychiatry. 2002 Feb 1;51(3):195-207
pubmed: 11839362
Phytochem Anal. 2010 Jan-Feb;21(1):22-32
pubmed: 19904730
Cerebellum Ataxias. 2020 Jun 26;7:8
pubmed: 32607248
Neuroimage. 2014 Oct 1;99:191-6
pubmed: 24875142
Biol Psychiatry. 2006 Jan 1;59(1):85-93
pubmed: 16289397
J Addict Res Ther. 2016 Aug;7(4):
pubmed: 27695638
Pharmacol Biochem Behav. 2013 Sep;110:174-84
pubmed: 23872369
Psychiatry Clin Neurosci. 2020 Jan;74(1):77-83
pubmed: 31599080
NMR Biomed. 2015 Oct;28(10):1315-23
pubmed: 26314380
Magn Reson Med. 2021 May;85(5):2359-2369
pubmed: 33216412
J Clin Neurosci. 2020 Jan;71:15-20
pubmed: 31859180
Magn Reson Med. 2007 Jul;58(1):27-33
pubmed: 17659613
Am J Psychiatry. 2021 Sep 1;178(9):829-837
pubmed: 34256607
Magn Reson Med. 2015 Dec;74(6):1523-9
pubmed: 25521836
Front Psychiatry. 2018 Sep 04;9:412
pubmed: 30233431
Hum Brain Mapp. 2016 Sep;37(9):3337-52
pubmed: 27145016
Am Fam Physician. 2013 Nov 1;88(9):589-95
pubmed: 24364635
Alcohol Clin Exp Res. 1995 Aug;19(4):1078-82
pubmed: 7485820
Eur Addict Res. 2018;24(6):267-277
pubmed: 30448826
Psychopharmacology (Berl). 2007 Aug;193(2):171-8
pubmed: 17393141
Neuroimage. 2021 Sep;238:118215
pubmed: 34058332
Neurosci Lett. 2008 Oct 10;443(3):236-40
pubmed: 18682277
Neuropharmacology. 2018 Mar 15;131:51-57
pubmed: 29221791
Neuropharmacology. 2006 Apr;50(5):632-9
pubmed: 16406445
NMR Biomed. 2001 Jun;14(4):260-4
pubmed: 11410943
Arch Gen Psychiatry. 2002 Sep;59(9):851-8
pubmed: 12215085
Seizure. 2021 Oct;91:213-227
pubmed: 34233236
J Magn Reson Imaging. 2020 Apr;51(4):1181-1191
pubmed: 31667944
Psychiatry Res. 1995 Nov 29;59(1-2):137-44
pubmed: 8771228
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:9-15
pubmed: 24246571
J Magn Reson Imaging. 2014 Dec;40(6):1445-52
pubmed: 25548816
Biochem Pharmacol. 2017 Nov 15;144:1-17
pubmed: 28599850
Nat Rev Neurosci. 2002 Sep;3(9):715-27
pubmed: 12209120
Magn Reson Med. 2008 Oct;60(4):964-9
pubmed: 18816817
Drug Alcohol Depend. 2012 Sep 1;125(1-2):27-36
pubmed: 22503310
Ann N Y Acad Sci. 2014 May;1316:53-70
pubmed: 24690001
Prog Nucl Magn Reson Spectrosc. 2012 Jan;60:29-41
pubmed: 22293397
Addict Biol. 2022 Jan;27(1):e13085
pubmed: 34390300
Curr Top Behav Neurosci. 2013;13:511-40
pubmed: 21688208
Addict Biol. 2016 Jan;21(1):205-17
pubmed: 25600822
Addict Biol. 2020 Nov;25(6):e12810
pubmed: 31373138
Psychopharmacology (Berl). 2021 May;238(5):1241-1254
pubmed: 31486875
Drug Alcohol Depend. 2017 Oct 1;179:117-123
pubmed: 28763779
Biol Psychiatry. 2005 Jan 1;57(1):44-8
pubmed: 15607299
Front Psychiatry. 2019 Jan 04;9:708
pubmed: 30662411
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5662-6
pubmed: 8516315
Physiol Rev. 2019 Oct 1;99(4):2115-2140
pubmed: 31507244
Neuropsychopharmacology. 2005 Feb;30(2):296-309
pubmed: 15483559
NMR Biomed. 2021 May;34(5):e4484
pubmed: 33559967
Br J Psychiatry. 2018 Jun;212(6):362-369
pubmed: 29716670
Neurochem Res. 2002 Mar;27(3):253-61
pubmed: 11958525
Neuropsychopharmacology. 2013 May;38(6):1113-20
pubmed: 23306182
NMR Biomed. 2006 Oct;19(6):690-701
pubmed: 16986118
Drug Alcohol Depend. 2013 Jun 1;130(1-3):30-7
pubmed: 23122599
Neuropsychol Rev. 2015 Sep;25(3):315-25
pubmed: 26264407
Neuropharmacology. 2015 Jan;88:36-47
pubmed: 24971600
Biol Sex Differ. 2019 Jan 14;10(1):5
pubmed: 30642393
Cochrane Database Syst Rev. 2018 Nov 26;11:CD012557
pubmed: 30484285
J Magn Reson Imaging. 2011 May;33(5):1262-7
pubmed: 21509888
Trends Neurosci. 2009 Jan;32(1):56-67
pubmed: 18986715
Neuropharmacology. 2014 Jan;76 Pt B:554-65
pubmed: 23752091
Biol Psychiatry. 2021 May 15;89(10):970-979
pubmed: 33581835
Alcohol Clin Exp Res. 2008 Sep;32(9):1558-64
pubmed: 18616673
Neuropharmacology. 2014 Dec;87:104-14
pubmed: 25080072
Magn Reson Med. 2013 Feb;69(2):317-20
pubmed: 22488982
NMR Biomed. 2016 Jul;29(7):932-42
pubmed: 27173449
Neuroimage. 2021 Jun;233:117930
pubmed: 33711485
Trends Cogn Sci. 2015 Jul;19(7):414-20
pubmed: 26066588
Brain Res. 2015 Feb 9;1597:129-38
pubmed: 25481417
J Clin Psychiatry. 2003;64 Suppl 3:7-14
pubmed: 12662128
Psychiatry Res Neuroimaging. 2021 Sep 30;315:111329
pubmed: 34271295
NMR Biomed. 2020 Aug 17;:e4347
pubmed: 32808407
Magn Reson Imaging. 2018 May;48:107-114
pubmed: 29306050
Front Psychiatry. 2021 Jul 05;12:656468
pubmed: 34290627
CNS Drugs. 2005;19(10):873-96
pubmed: 16185095
Alcohol. 2013 Feb;47(1):69-73
pubmed: 23218664
NMR Biomed. 2021 May;34(5):e4199
pubmed: 31658398
Neurochem Int. 2007 Jan;50(2):386-94
pubmed: 17074420
Neuroimage. 2014 Feb 1;86:43-52
pubmed: 23246994
Eur J Radiol. 2010 Mar;73(3):526-31
pubmed: 19201120
Drug Alcohol Depend. 2008 Jun 1;95(3):284-7
pubmed: 18374518
Neuropharmacology. 2011 Jun;60(7-8):1318-25
pubmed: 21276806
NMR Biomed. 1998 Oct;11(6):266-72
pubmed: 9802468
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
Brain Sci. 2021 Nov 19;11(11):
pubmed: 34827537
Open J Radiol. 2017 Mar;7(1):35-44
pubmed: 28690923
Front Pharmacol. 2019 Jul 02;10:720
pubmed: 31312138
J Magn Reson Imaging. 2015 Nov;42(5):1431-40
pubmed: 26172043
AJNR Am J Neuroradiol. 2020 Jul;41(7):1293-1301
pubmed: 32616578
Alcohol Clin Exp Res. 2019 Feb;43(2):221-226
pubmed: 30537347
Transl Psychiatry. 2017 Jul 4;7(7):e1163
pubmed: 28675386
NMR Biomed. 2021 May;34(5):e4411
pubmed: 32946145
Lancet. 2007 Dec 8;370(9603):1915-22
pubmed: 18068515
Neuroimage. 2019 May 1;191:537-548
pubmed: 30840905
Psychiatry Res. 2004 Apr 30;130(3):283-93
pubmed: 15135161
Am J Psychiatry. 2005 Aug;162(8):1403-13
pubmed: 16055761
J Magn Reson Imaging. 2017 Aug;46(2):421-430
pubmed: 28205280
Pharmacol Biochem Behav. 2021 Jan;200:173090
pubmed: 33333132
J Neurosci Methods. 2018 Jun 1;303:86-94
pubmed: 29476871
Neurosci Biobehav Rev. 2016 Feb;61:35-52
pubmed: 26657968
Neuropsychopharmacology. 2005 Nov;30(11):2065-72
pubmed: 15841108

Auteurs

Claire Shyu (C)

Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON M5S 2S1, Canada.
Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada.
Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8, Canada.

Sofia Chavez (S)

Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada.
Institute of Medical Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada.
Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, ON M5T 1R8, Canada.
Department of Psychiatry, Division of Brain and Therapeutics, University of Toronto, Toronto, ON M5T 1R8, Canada.

Isabelle Boileau (I)

Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada.
Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Institute of Medical Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada.
Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, ON M5T 1R8, Canada.
Department of Psychiatry, Division of Brain and Therapeutics, University of Toronto, Toronto, ON M5T 1R8, Canada.

Bernard Le Foll (B)

Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON M5S 2S1, Canada.
Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada.
Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Institute of Medical Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada.
Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, ON M5T 1R8, Canada.
Department of Psychiatry, Division of Brain and Therapeutics, University of Toronto, Toronto, ON M5T 1R8, Canada.
Centre for Addiction and Mental Health, Concurrent Outpatient Medical & Psychosocial Addiction Support Services, Toronto, ON M6J 1H4, Canada.
Centre for Addiction and Mental Health, Acute Care Program, Toronto, ON M6J 1H3, Canada.
Department of Family and Community Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada.
Waypoint Centre for Mental Health Care, Waypoint Research Institute, 500 Church Street, Penetanguishene, ON L9M 1G3, Canada.

Classifications MeSH